MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.

Abstract:

:MRP14 (S100A9) is the major calcium-binding protein of neutrophils and monocytes. Targeted gene disruption reveals an essential role of this S100 protein for transendothelial migration of phagocytes. The underlying molecular mechanism comprises major alterations of cytoskeletal metabolism. MRP14, in complex with its binding partner MRP8 (S100A8), promotes polymerization of microtubules. MRP14 is specifically phosphorylated by p38 mitogen-activated protein kinase (MAPK). This phosphorylation inhibits MRP8/MRP14-induced tubulin polymerization. Phosphorylation of MRP14 is antagonistically regulated by binding of MRP8 and calcium. The biologic relevance of these findings is confirmed by the fact that MAPK p38 fails to stimulate migration of MRP14(-/-) granulocytes in vitro and MRP14(-/-) mice show a diminished recruitment of granulocytes into the granulation tissue during wound healing in vivo. MRP14(-/-) granulocytes contain significantly less polymerized tubulin, which subsequently results in minor activation of Rac1 and Cdc42 after stimulation of p38 MAPK. Thus, the complex of MRP8/MRP14 is the first characterized molecular target integrating MAPK- and calcium-dependent signals during migration of phagocytes.

journal_name

Blood

journal_title

Blood

authors

Vogl T,Ludwig S,Goebeler M,Strey A,Thorey IS,Reichelt R,Foell D,Gerke V,Manitz MP,Nacken W,Werner S,Sorg C,Roth J

doi

10.1182/blood-2004-02-0446

subject

Has Abstract

pub_date

2004-12-15 00:00:00

pages

4260-8

issue

13

eissn

0006-4971

issn

1528-0020

pii

2004-02-0446

journal_volume

104

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A clinical study of the lupus anticoagulant.

    abstract::Eighty-three patients with circulating anticoagulants were studied at The New York Hospital. The lupus-type anticoagulant, an inhibitor of the prothrombin activator complex, was demonstrated in 58 patients. The inhibitor was identified using the blood and tissue thromboplastin inhibition tests. Inhibition by the lupus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schleider MA,Nachman RL,Jaffe EA,Coleman M

    更新日期:1976-10-01 00:00:00

  • T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.

    abstract::T-cell depletion (TCD) of the donor marrow graft has been shown to reduce the severity of graft-versus-host disease (GVHD) in patients with chronic-phase (CP) chronic myelogenous leukemia (CML) undergoing HLA-identical sibling allogeneic marrow transplantation. However, there has been a corresponding reduction in the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Drobyski WR,Hessner MJ,Klein JP,Kabler-Babbitt C,Vesole DH,Margolis DA,Keever-Taylor CA

    更新日期:1999-07-15 00:00:00

  • The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.

    abstract::The treatment of multiple myeloma has evolved significantly over the last decades from primarily alkylator-based chemotherapeutic agents with minimal efficacy to the introduction of more effective agents including immune modulators and proteasome inhibitors, which have changed the landscape of therapy for this disease...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-05-636357

    authors: Hoyos V,Borrello I

    更新日期:2016-09-29 00:00:00

  • T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10.

    abstract::Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related fatalities and is characterized by acute respiratory distress following blood transfusion. Donor antibodies are frequently involved; however, the pathogenesis and protective mechanisms in the recipient are poorly understood, and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-12-758185

    authors: Kapur R,Kim M,Aslam R,McVey MJ,Tabuchi A,Luo A,Liu J,Li Y,Shanmugabhavananthan S,Speck ER,Zufferey A,Yousef G,Zhang H,Rondina MT,Weyrich AS,Porcelijn L,Kuebler WM,Slutsky AS,Semple JW

    更新日期:2017-05-04 00:00:00

  • Contribution of distinct adhesive interactions to platelet aggregation in flowing blood.

    abstract::Aggregation of blood platelets contributes to the arrest of bleeding at sites of vascular injury, but it can occlude atherosclerotic arteries and precipitate diseases such as myocardial infarction. The bonds that link platelets under flow conditions were identified using confocal videomicroscopy in real time. Glycopro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ruggeri ZM,Dent JA,Saldívar E

    更新日期:1999-07-01 00:00:00

  • Characterization of the mononuclear phagocyte system in zebrafish.

    abstract::The evolutionarily conserved immune system of the zebrafish (Danio rerio), in combination with its genetic tractability, position it as an excellent model system in which to elucidate the origin and function of vertebrate immune cells. We recently reported the existence of antigen-presenting mononuclear phagocytes in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-321448

    authors: Wittamer V,Bertrand JY,Gutschow PW,Traver D

    更新日期:2011-06-30 00:00:00

  • Interleukin-3 treatment of rhesus monkeys leads to increased production of histamine-releasing cells that express interleukin-3 receptors at high levels.

    abstract::To understand the hematopoietic and nonhematopoietic responses to interleukin-3 (IL-3), expression of cell-surface IL-3 receptors (IL-3R) was examined on bone marrow (BM) cells and peripheral blood (PB) cells of rhesus monkeys during the course of in vivo IL-3 treatment. Whereas IL-3R expression is low in untreated mo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Gils FC,van Teeffelen ME,Neelis KJ,Hendrikx J,Burger H,van Leen RW,Knol E,Wagemaker G,Wognum AW

    更新日期:1995-07-15 00:00:00

  • Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3.

    abstract::Follicular lymphoma (FL) grades 1 and 2 are regarded as a distinct disease entity, whereas data suggest that FL grade 3 might be an inhomogeneous tumor category. To define the biologic spectrum of FL, 89 follicular lymphomas were studied for their cytologic composition, antigen expression, mitotic and proliferation in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3806

    authors: Ott G,Katzenberger T,Lohr A,Kindelberger S,Rüdiger T,Wilhelm M,Kalla J,Rosenwald A,Müller JG,Ott MM,Müller-Hermelink HK

    更新日期:2002-05-15 00:00:00

  • Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

    abstract::A semiquantitative polymerase chain reaction assay was used to monitor the blood levels of Epstein-Barr virus (EBV)-DNA in 9 patients receiving allogeneic bone marrow transplants (BMT). Four of 5 recipients of HLA-mismatched T-cell-depleted grafts showed a 4- to 5-log increase of EBV-DNA within 1 to 3 months after BMT...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gustafsson A,Levitsky V,Zou JZ,Frisan T,Dalianis T,Ljungman P,Ringden O,Winiarski J,Ernberg I,Masucci MG

    更新日期:2000-02-01 00:00:00

  • Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells.

    abstract::Dendritic cell (DC) homeostasis in peripheral tissues reflect a balance between DC generation, migration, and death. The current model of DC ontogeny indicates that pre-cDCs are committed to become terminal conventional DCs (cDCs). Here, we report the unexpected finding that proliferating immunostimulatory CD11c(+) MH...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-11-392894

    authors: Diao J,Mikhailova A,Tang M,Gu H,Zhao J,Cattral MS

    更新日期:2012-05-24 00:00:00

  • Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice.

    abstract::It has been reported that the intracellular antiapoptotic factor myeloid cell leukemia sequence 1 (Mcl-1) is required for mast cell survival in vitro, and that genetic manipulation of Mcl-1 can be used to delete individual hematopoietic cell populations in vivo. In the present study, we report the generation of C57BL/...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-343962

    authors: Lilla JN,Chen CC,Mukai K,BenBarak MJ,Franco CB,Kalesnikoff J,Yu M,Tsai M,Piliponsky AM,Galli SJ

    更新日期:2011-12-22 00:00:00

  • G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

    abstract::Src activation involves the coordinated regulation of positive and negative tyrosine phosphorylation sites. The mechanism whereby receptor tyrosine kinases, cytokine receptors, and integrins activate Src is not known. Here, we demonstrate that granulocyte colony-stimulating factor (G-CSF) activates Lyn, the predominan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-261636

    authors: Futami M,Zhu QS,Whichard ZL,Xia L,Ke Y,Neel BG,Feng GS,Corey SJ

    更新日期:2011-07-28 00:00:00

  • Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.

    abstract::Using 2-dimensional gel electrophoresis (2D-gel) analysis, we show here that cell-cycle entry is associated with a significant increase in p27(kip1) phosphorylation in human primary B cells. A similar pattern of increase in p27(kip1) phosphorylation was also seen in 2 fast-growing tumor cell lines, Burkitt lymphoma ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2558

    authors: Zhang W,Bergamaschi D,Jin B,Lu X

    更新日期:2005-05-01 00:00:00

  • Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile.

    abstract::High levels of coagulation factor VIII (FVIII) have been associated with cardiovascular disease. Low-density lipoprotein receptor (LDLR) has been recently demonstrated to contribute to FVIII clearance from plasma. The aim of this study was to evaluate 3 single nucleotide polymorphisms in SMARCA4-LDLR gene locus (rs112...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-03-277079

    authors: Martinelli N,Girelli D,Lunghi B,Pinotti M,Marchetti G,Malerba G,Pignatti PF,Corrocher R,Olivieri O,Bernardi F

    更新日期:2010-12-16 00:00:00

  • Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.

    abstract::Erythroid progenitor cells isolated from patients with polycythemia vera (PV) proliferate and differentiate in methylcellulose in the absence of exogenous erythropoietin (EPO). To investigate the potential role of the erythropoietin receptor (EPO-R) in the pathogenesis of PV, we cultured bone marrow-derived or periphe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fisher MJ,Prchal JF,Prchal JT,D'Andrea AD

    更新日期:1994-09-15 00:00:00

  • Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide.

    abstract::Cell suspensions of normal rat marrow mixed with rat acute myelogenous leukemic cells were prepared and incubated in vitro with graded doses of 4-hydroperoxycyclophosphamide (4HC). The cell suspensions were injected into rats prepared with a lethal dose of total body irradiation. Animals injected with these cells surv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sharkis SJ,Santos GW,Colvin M

    更新日期:1980-03-01 00:00:00

  • Cyclin A1 expression in leukemia and normal hematopoietic cells.

    abstract::Human cyclin A1 is a newly cloned, tissue-specific cyclin that is prominently expressed in normal testis. In this study, we showed that cyclin A1 was highly expressed in a subset of leukemia samples from patients. The highest frequency of cyclin A1 overexpression was observed in acute myelocytic leukemias, especially ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yang R,Nakamaki T,Lübbert M,Said J,Sakashita A,Freyaldenhoven BS,Spira S,Huynh V,Müller C,Koeffler HP

    更新日期:1999-03-15 00:00:00

  • Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD.

    abstract::CD8+ Foxp3+ T cells (Tregs) are a potent regulatory population whose functional and ontological similarities to CD4+ Fox3+ T cells have not been well delineated. Using an experimental model of graft-versus-host disease (GVHD), we observed that CD8+ Tregs were significantly less potent than CD4+ Tregs for the suppressi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-09-807156

    authors: Agle K,Vincent BG,Piper C,Belle L,Zhou V,Shlomchik W,Serody JS,Drobyski WR

    更新日期:2018-07-26 00:00:00

  • Viral, immunologic, and clinical features of primary effusion lymphoma.

    abstract::Primary effusion lymphoma (PEL) is an aggressive HIV-associated lymphoma with a relatively poor prognosis in the era of effective HIV therapy. Kaposi sarcoma herpesvirus (KSHV) is the etiologic agent, and ∼80% of tumors are coinfected with Epstein-Barr virus (EBV). A better understanding of how KSHV-related immune dys...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2019-01-893339

    authors: Lurain K,Polizzotto MN,Aleman K,Bhutani M,Wyvill KM,Gonçalves PH,Ramaswami R,Marshall VA,Miley W,Steinberg SM,Little RF,Wilson W,Filie AC,Pittaluga S,Jaffe ES,Whitby D,Yarchoan R,Uldrick TS

    更新日期:2019-04-18 00:00:00

  • Long noncoding RNAs in biology and hematopoiesis.

    abstract::Genome and transcriptome sequencing have revealed a rich assortment of noncoding RNAs in eukaryote cells, including long noncoding RNAs (lncRNAs), which regulate gene expression independent of protein coding potential. LncRNAs modulate protein coding gene expression in many cell types by regulating multiple processes,...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2013-03-456111

    authors: Paralkar VR,Weiss MJ

    更新日期:2013-06-13 00:00:00

  • Hematologic effects of stem cell factor in vivo and in vitro in rodents.

    abstract::Recombinant rat stem cell factor (rrSCF) administered to rats as a single intravenous injection causes a dose-dependent neutrophilia and lymphocytosis as well as the appearance of immature myeloid cells and occasional blast cells in the circulation. Neutrophilia begins at 2 hours, peaks at 4 to 6 hours, and subsides b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ulich TR,del Castillo J,Yi ES,Yin S,McNiece I,Yung YP,Zsebo KM

    更新日期:1991-08-01 00:00:00

  • AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.

    abstract::Emerging successful clinical data on gene therapy using adeno-associated viral (AAV) vector for hemophilia B (HB) showed that the risk of cellular immune response to vector capsid is clearly dose dependent. To decrease the vector dose, we explored AAV-8 (1-3 × 10(12) vg/kg) encoding a hyperfunctional factor IX (FIX-Pa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-588194

    authors: Crudele JM,Finn JD,Siner JI,Martin NB,Niemeyer GP,Zhou S,Mingozzi F,Lothrop CD Jr,Arruda VR

    更新日期:2015-03-05 00:00:00

  • Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.

    abstract::Studies with the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3) fusion protein, PIXY321, demonstrated enhanced biological activity of this molecule in comparison with GM-CSF or IL-3 alone or in combination. Experiments were performed to study the mechanisms resulting in PIXY321-induced ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mignacca RC,Lee HJ,Kwon EM,Sakamoto KM

    更新日期:1996-08-01 00:00:00

  • Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF.

    abstract::We report long-term results of treatment of myelodysplastic syndrome (MDS) with erythropoietin and granulocyte colony-stimulating factor (G-CSF). A total of 129 patients were followed up 45 months after last inclusion in the Nordic MDS Group studies. Erythroid response rate was 39% and median response duration 23 mont...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-10-3872

    authors: Jädersten M,Montgomery SM,Dybedal I,Porwit-MacDonald A,Hellström-Lindberg E

    更新日期:2005-08-01 00:00:00

  • ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.

    abstract::Cyclin dependent kinase (CDK) inhibitors, such as flavopiridol, demonstrate significant single-agent activity in chronic lymphocytic leukemia (CLL), but the mechanism of action in these nonproliferating cells is unclear. Here we demonstrate that CLL cells undergo autophagy after treatment with therapeutic agents, incl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-400184

    authors: Mahoney E,Lucas DM,Gupta SV,Wagner AJ,Herman SE,Smith LL,Yeh YY,Andritsos L,Jones JA,Flynn JM,Blum KA,Zhang X,Lehman A,Kong H,Gurcan M,Grever MR,Johnson AJ,Byrd JC

    更新日期:2012-08-09 00:00:00

  • KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.

    abstract::The transcription factor KLF4 may act both as an oncogene and a tumor suppressor in a tissue-depending manner. In T- and pre-B-cell lymphoma, KLF4 was found to act as tumor suppressor. We found the KLF4 promoter methylated in B-cell lymphoma cell lines and in primary cases of B-cell lymphomas, namely, follicular lymph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-256446

    authors: Guan H,Xie L,Leithäuser F,Flossbach L,Möller P,Wirth T,Ushmorov A

    更新日期:2010-09-02 00:00:00

  • In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.

    abstract::Transforming growth factor-beta1 (TGF-beta1) has potent physiologic and pathologic effects on a variety of cell types at subnanomolar concentrations. Platelets contain 40 times as much TGF-beta1 as other cells and secrete it as an inactive (latent) form in complex with latency-associated peptide (LAP), which is disulf...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151753

    authors: Ahamed J,Burg N,Yoshinaga K,Janczak CA,Rifkin DB,Coller BS

    更新日期:2008-11-01 00:00:00

  • Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia.

    abstract::Chimeric antigen receptor (CAR) T cells have radically improved the treatment of B cell-derived malignancies by targeting CD19. The success has not yet expanded to treat acute myeloid leukemia (AML). We developed a Sequentially Tumor-Selected Antibody and Antigen Retrieval (STAR) system to rapidly isolate multiple nan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019002779

    authors: He X,Feng Z,Ma J,Ling S,Cao Y,Gurung B,Wu Y,Katona BW,O'Dwyer KP,Siegel DL,June CH,Hua X

    更新日期:2020-03-05 00:00:00

  • Thrombopoietin therapy increases platelet yields in healthy platelet donors.

    abstract::The recombinant thrombopoietins have been shown to be effective stimulators of platelet production in cancer patients. It was therefore of interest to determine if one of these, pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF), could be used to increase platelet counts and conseque...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood.v98.5.1339

    authors: Kuter DJ,Goodnough LT,Romo J,DiPersio J,Peterson R,Tomita D,Sheridan W,McCullough J

    更新日期:2001-09-01 00:00:00

  • Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

    abstract::An acquired gain-of-function mutation in the Janus kinase 2 (JAK2-V617F) is frequently found in patients with myeloproliferative disorders (MPDs). To test the hypothesis that JAK2-V617F is the disease-initiating mutation, we examined whether all cells of clonal origin carry the JAK2-V617F mutation. Using allele-specif...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2005-11-009605

    authors: Kralovics R,Teo SS,Li S,Theocharides A,Buser AS,Tichelli A,Skoda RC

    更新日期:2006-08-15 00:00:00